Search SNYR
Synergy CHC Corp.
OTC · CIK 1562733
Last close0.09
Daily changen/a
10 Years gain-99.84%
Dividends TTM0
Dividend yieldn/a
Fundamental Analysis
SNYR · STANDARD
SIC 2833 · Medicinal Chemicals & Botanical Products · Fiscal year end 1231
Fundamental
54.0Momentum
28.7Acceleration
28.7Confidence
76.0Annual Revenue9
Quarterly Revenue26
Annual CFO10
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth0.4 / 25
Quality18.5 / 25
Capital Efficiency20.0 / 20
Balance Sheet2.4 / 15
Shareholder Economics10.0 / 10
Forward Indicators0.0 / 5
Signals
Gross margin expansionGross margin improved by 3.5325 percentage points.
Warnings
Inventory anomaly · MEDIUMInventory growth is materially above revenue growth.
Operating margin compression · MEDIUMOperating margin compressed by 4.2639 percentage points.
Heavy share dilution · HIGHDiluted share count increased 53.2987%.
Key Metrics
Revenue Growth TTM-15.72%OK
Revenue CAGR 3Y1.15%OK
Gross Margin73.99%OK
Operating Margin14.37%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROICn/aMISSING
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y53.3%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $30.38M | $20.30M | -$8.46M | -$2.59M | n/a | 66.83% | -27.84% | n/a | n/a | 9.72M |
| 2025 FY Dec 31, 2024 | $34.83M | $23.64M | $5.80M | -$4.80M | n/a | 67.87% | 16.65% | n/a | n/a | 7.63M |
| 2024 FY Dec 31, 2023 | $42.78M | $32.08M | $10.81M | $421,729.00 | n/a | 74.99% | 25.26% | n/a | n/a | 7.37M |
| 2019 FY Dec 31, 2019 | $29.36M | $20.22M | -$7.96M | $2.95M | n/a | 68.87% | -27.1% | n/a | n/a | n/a |
| 2019 FY Dec 31, 2018 | $33.82M | $22.79M | -$4.92M | $1.30M | $1.18M | 67.37% | -14.54% | 3.48% | -70.53% | n/a |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $29.81M | sum latest 4 fiscal quarters Revenue | OK | 0001213900-26-056237, 0001213900-25-076060 |
| Revenue Growth TTM | -15.72% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001213900-26-056237, 0001213900-25-076060 |
| Revenue CAGR 3Y | 1.15% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001213900-26-037883 |
| Revenue CAGR 5Y | -3.12% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001213900-26-037883 |
| Gross Profit CAGR 3Y | 0.14% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001213900-26-037883 |
| Operating Income Growth | -35% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0001213900-26-056237, 0001213900-25-076060 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 73.99% | Gross Profit / Revenue | OK | 0001213900-26-056237, 0001213900-25-076060 |
| Operating Margin | 14.37% | Operating Income / Revenue | OK | 0001213900-26-056237, 0001213900-25-076060 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001213900-26-056237 |
| Current Ratio | 0.93x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 0.01x | (Cash + Short-term Investments) / Total Debt | OK | 0001213900-26-056237 |
| Revenue per Diluted Share | $2.64 | Revenue / Diluted Shares | OK | 0001213900-26-056237, 0001213900-25-076060 |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |